Related Experiment Video
Updated: May 5, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues
Tali Garin-Shkolnik1, Assaf Rudich, Gökhan S Hotamisligil
1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Abstract:
Fatty acid binding protein 4 (FABP4, also known as aP2) is a cytoplasmic fatty acid chaperone expressed primarily in adipocytes and myeloid cells and implicated in the development of insulin resistance and atherosclerosis. Here we demonstrate that FABP4 triggers the ubiquitination and subsequent proteasomal degradation of peroxisome proliferator-activated receptor γ (PPARγ), a master regulator of adipogenesis and insulin responsiveness. Importantly, FABP4-null mouse preadipocytes as well as macrophages exhibited increased expression of PPARγ, and complementation of FABP4 in the macrophages reversed the increase in FABP4 expression. The FABP4-null preadipocytes exhibited a remarkably enhanced adipogenesis compared with wild-type cells, indicating that FABP4 regulates adipogenesis by downregulating PPARγ. We found that the FABP4 level was higher and PPARγ level was lower in human visceral fat and mouse epididymal fat compared with their subcutaneous fat. Furthermore, FABP4 was higher in the adipose tissues of obese diabetic individuals compared with healthy ones. Suppression of PPARγ by FABP4 in visceral fat may explain the reported role of FABP4 in the development of obesity-related morbidities, including insulin resistance, diabetes, and atherosclerosis.
Insights
Fatty acid binding protein 4 (FABP4) promotes the breakdown of a key protein, PPARγ, hindering fat cell development. This discovery sheds light on obesity-related diseases like insulin resistance and atherosclerosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Metabolic Diseases
Background:
- Fatty acid binding protein 4 (FABP4) is a cytoplasmic protein found in adipocytes and myeloid cells.
- FABP4 is linked to the development of insulin resistance and atherosclerosis.
- Peroxisome proliferator-activated receptor γ (PPARγ) is a crucial regulator of adipogenesis and insulin sensitivity.
Purpose of the Study:
- To investigate the molecular mechanism by which FABP4 influences PPARγ activity.
- To determine the role of FABP4 in regulating adipogenesis and its implications in metabolic diseases.
Main Methods:
- Utilized FABP4-null mouse preadipocytes and macrophages.
- Performed complementation assays to restore FABP4 expression.
- Analyzed PPARγ expression and ubiquitination.
- Assessed adipogenesis in wild-type and FABP4-null cells.
- Compared FABP4 and PPARγ levels in human and mouse adipose tissues from healthy and obese diabetic individuals.
Main Results:
- FABP4 was found to trigger the ubiquitination and proteasomal degradation of PPARγ.
- FABP4-null cells showed increased PPARγ expression and enhanced adipogenesis.
- FABP4 levels were higher and PPARγ levels lower in visceral fat compared to subcutaneous fat.
- Elevated FABP4 and reduced PPARγ were observed in adipose tissues of obese diabetic individuals.
Conclusions:
- FABP4 negatively regulates adipogenesis by promoting PPARγ degradation.
- FABP4-mediated suppression of PPARγ in visceral fat contributes to obesity-related morbidities.
- Targeting FABP4 may offer a therapeutic strategy for insulin resistance, diabetes, and atherosclerosis.
More Related Videos
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
13:26Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker
Published on: March 31, 2018
Related Concept Videos
Cell Specific Gene Expression
GPCRs Regulate Adenylyl Cylase Activity
cAMP-dependent Protein Kinase Pathways
Abnormal Proliferation
Master Transcription Regulators